FDA CASSS Interface of Regulatory and Analytical Sciences for Biotechnology Health Products

This Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. Hear from and engage with thought leaders on a wide range of topics including CMC development strategies, innovative analytical characterization, global submission strategies, next-generation therapeutics & vaccines, as well as the challenges and promises of CRISPR-based therapeutics, which are poised to revolutionize the future of medicine. Be ready to network, collaborate, and expand your knowledge.

LOCATION

The Mayflower Hotel
1127 Connecticut Avenue NW
Washington D.C. 20036

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

WCBP Symposium 2024 - 01/23/2024

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.